Deals
iBio Raises $2M at 38% Premium From Eastern Capital
|
iBio (AMEX:IBIO) announced that it has raised $2,177,000 in a Common Stock transaction
Growth Capitalist (https://growthcapitalist.com/category/deals/page/60/)
Recent growth capital transactions by pre-IPO private and public emerging growth companies
iBio (AMEX:IBIO) announced that it has raised $2,177,000 in a Common Stock transaction
PharmaCyte Biotech (OTC:PMCB) announced that it has raised $1,020,000 in a Common Stock transaction.
SPI Energy Company Limited (OTC:SRGYY) announced that it has raised $5,000,000 in a Common Stock transaction pursuant tot Regulation S.
Apricus Biosciences (OTC:APRI) announced that it has raised $10,000,003 in a Registered Direct transaction.